Clinical Factors Associated With Pediatric Brain Neoplasms
A study pinpointed clinical factors associated with pediatric brain neoplasms to assist clinicians in making neuroimaging decisions.
Brain Tumors
No Survival Benefit With Lomustine Plus Bevacizumab in Glioblastoma
Treatment with lomustine plus bevacizumab does not show a survival advantage over treatment with lomustine alone in patients with glioblastoma.
Temozolomide Plus Radiotherapy Improves Survival in Non-Co-Deleted Glioma
1p/19q non-co-deleted anaplastic gliomas are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumors.
Increased Survival For Melanoma Brain Metastases
In patients with melanoma brain metastases, overall survival has increased since 2000.
Postoperative Stereotactic Radiosurgery Reduces Recurrence After Metastases Resection
The use of postoperative stereotactic radiosurgery could be a substitute for whole-brain radiotherapy, which has been linked to cognitive adverse effects.
Glioblastoma Treatment May Benefit From Vaccine-Chemotherapy Combo
Nearly half of the patients in the trial survived more than 5 years after they were given the vaccine-chemotherapy treatment.
Researchers Debunk Rumored Link Between Glioblastoma, Cytomegalovirus
Despite previous reports, researchers have found no signs of a link between cytomegalovirus and brain tumors including glioblastoma.
HER2-Negative Breast Cancer Turns Positive in the Brain
Molecular changes occur to cancer cells when they spread to the brain.
Radiomic Method Helps Predicts Glioblastoma Outcome
Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS.
Increasing PORT Deferral in Medulloblastoma Raises Mortality Risk
Despite it being a standard of care, more or more pediatric patients are deferring PORT.
- Loading...
Loading...
Next post in Brain Tumors
Loading... 
Loading...